Connexion
E-mail
Mot de passe
Afficher le mot de passe
Retenir
Mot de passe oublié ?
Devenir membre gratuitement
Inscription
Inscription
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Paramètres
Paramètres
Cotations dynamiques 
OFFON

ROCHE HOLDING AG

(RO)
  Rapport
SynthèseCotationsGraphiquesActualitésNotationsAgendaSociétéFinancesConsensusRévisionsDérivésFondsCommunauté 
SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur ROCHE HOLDING AG
03/12Paul Bulcke tritt nicht mehr als Roche-Verwaltungsrat an
03/12PAUL BULCKE : Roche says Nestle Chairman Bulcke to leave its board of directors
03/12Roche to Name New Member to Board of Directors, Re-Elect Chairman
03/12PAUL BULCKE : Paul Bulcke tritt nicht mehr zur Wiederwahl für Verwaltungsrat an
03/12ROCHE : Änderungen im Verwaltungsrat von Roche
03/12Changes in the Board of Directors
03/12Roche-Mittel Rituximab in den USA für Jugendliche mit Lymphkrebs zugelassen
03/12REMINDER : Invitation to Roche's virtual analyst event during ESMO IO
03/12Roche develops new research test kits for Omicron variant
03/12CORONA-BLOG/Roche entwickelt Tests zur Mutationen-Differenzierung
03/12Roche-Tochter TIB Molbiol hat Testmöglichkeiten für Omikron-Variante entwickelt
03/12Roche Unveils Three Testing Kits to Identify Omicron Variant Mutations
03/12Roche develops new test kits for COVID-19 Omicron variant
03/12Roche has rapidly developed additional testing options to differentiate mutations in th..
03/12Roche Rapidly Developed Additional Testing Options to Differentiate Mutations in the Om..
02/12Chugai Launches a New Educational Website 'So-Zo LABO' Aiming for a Society that Embrac..
02/12WDH : Novartis setzt der Generikakonkurrenz potenzielle Kassenschlager entgegen
01/12Jazz Pharmaceuticals Announces First Patient Enrolled in IMforte Phase 3 Trial Evaluati..
01/12Jerome, ese gran loco
01/12Roche schliesst Übernahme von langjährigem Partner TIB Molbiol ab
01/12Roche Closes Biotechnology Group TIB Molbiol Acquisition
01/12Roche completes purchase agreement with long-term partner TIB Molbiol to expand PCR-tes..
01/12Roche Holding AG acquired of Tib Molbiol.
30/11Aktien Schweiz etwas leichter - Erneute Omikron-Sorgen belasten
30/11WDH : Roche-Tests erkennen Corona-Infektion mit Omikron-Variante sicher
30/11Roche Uses Amazon Web Services For Most Cloud Needs
29/11Thermo Fisher says its COVID-19 tests accurately detects Omicron variant
29/11Aktien Schweiz mit leichter Erholung von Kursrutsch am "Black Friday"
26/11Aktien Schweiz knicken mit Corona-Ängsten ein - Logitech und Lonza fester
26/11Chugai Pharmaceutical Co. - Anti Cancer Agent Herceptin Approved for Additional Indicat..
26/11Roche Shareholders Approve Deal to Buy Back Novartis' Stake in Swiss Drugmaker
26/11Roche-Aktionäre segnen Rückkauf von Novartis-Anteil ab
26/11Roche shareholders approve deal to buy Novartis's $20.7 billion stake
26/11Roche Shareholders OK $21 Billion Repurchase Deal With Novartis
26/11Roche shareholders approve deal to buy Novartis's $20.7 billion stake
26/11Roche Extraordinary General Meeting 2021
25/11Aktien Schweiz schließen mit Aufschlägen
24/11Aktien Schweiz zur Wochenmitte mit moderaten Aufschlägen
24/11Beijing IP Court To Hear China's First Case Of Patent Linkage
23/11Aktien Schweiz schließen schwach - Partners Group sacken ab
23/11Roche stellt an ASH 2021 neue Daten zur Behandlung von Blutkrankheiten vor
23/11Genentech to Present New Pivotal Data at ASH 2021 From Broad and Comprehensive Portfoli..
23/11Roche to present new pivotal data at ASH 2021 from broad and comprehensive portfolio, c..
23/11Roche to Present New Pivotal Data at ASH 2021 from Broad and Comprehensive Portfolio, C..
22/11Aktien Schweiz schließen etwas leichter - Julius Bär unter Druck
22/11NICE draft guidance recommends new treatment for spinal muscular atrophy as part of a m..
19/11EQT, BioNTech investor consider bid for Novartis arm Sandoz -report
19/11Aktien Schweiz schließen knapp behauptet - Logitech fest
19/11Roche Gets European Commission's Marketing Authorization for Lung Cancer Drug Gavreto
19/11Roche erhält EU-Zulassung für Lungenkrebsmittel Gavreto
19/11European Commission approves Roche's Gavreto (pralsetinib) for the treatment of adults ..
19/11European Commission Approves Roche?s Gavreto (Pralsetinib) for the Treatment of Adults ..
18/11Aktien Schweiz schließen etwas leichter - Holcim unter Druck
18/11Shell, Nedbank, FedEx, AWS, Roche, AGRA, City of Johannesburg and PayFast Partner for A..
18/11Shell, Nedbank, FedEx, AWS, Roche, AGRA, City of Johannesburg and PayFast Partner for A..
18/11Novartis Said Considering Takeover in Biotech Sector
18/11¿Habrá consumo en Navidad?
18/11Roche Launches New PCR Molecular Testing Instrument
18/11Roche lanciert neues Molekulardiagnostiksystem Cobas 5800
18/11Roche launches cobas 5800, a new molecular diagnostics system to expand access to testi..
18/11Roche Announces the Launch of the Cobas? 5800 System
17/11GLOBAL MARKETS LIVE : Tesla, Experian, Roche, Activision, Amazon...
17/11Atea Pharma Shares Drop 16% After Collaboration With Roche Terminated
17/11Roche erwartet für Diagnostics-Sparte auch nach Corona Wachstum
17/11Los árboles no llegan hasta el cielo, pero estamos muy arriba, ¿no?
17/11Roche beendet Partnerschaft mit Atea für Corona-Pille
17/11Roche, Atea Pharmaceuticals Cancel COVID-19 Therapy Development Partnership
16/11Roche walks away from Atea partnership to develop COVID-19 pill
16/11Atea Pharma says deal to develop COVID-19 pill with Roche terminated
16/11Chugai Continuously Selected in the 'DJSI World,' a Global ESG Investment Index
16/11ROCHE : Invitation to Roche's virtual event on key hematology data presented at ASH 2021
15/11Aktien Schweiz schließen wenig verändert - Richemont gesucht
15/11ROCHE : Invitation to Roche's virtual analyst event during ESMO IO
15/11ROCHE-GV : Ethos lehnt Vernichtung der Stimmrechtsaktien ab
15/11Roche Selected Among Dow Jones' Top Sustainable Healthcare Companies
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur ROCHE HOLDING AG